Company / Book Value per Share
Avalo Therapeutics, Inc. Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.931
FY2025
5-year range
-$1.161 / $185.881
FY2021-FY2025
Trend
-95.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 9 years, ranging from -$1.161 in FY2022 to $185.881 in FY2023.
Based on SEC 10-K filings.
$7.931 in FY2025 with a 5-year CAGR of +70.3%.
Declined from $185.881 to $7.931 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +70.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +70.3%, indicating consistent growth.
- In FY2025, book value per share decreased 95.2% year-over-year.
- Peak book value per share was recorded in FY2023.
- Lowest book value per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.931 | -95.2% |
| FY2024 | $165.928 | -10.7% |
| FY2023 | $185.881 | +16107.2% |
| FY2022 | -$1.161 | -477.3% |
| FY2021 | $0.308 | -44.4% |
| FY2020 | $0.553 | +7.5% |
| FY2019 | $0.515 | -23.0% |
| FY2018 | $0.669 | -77.4% |
| FY2017 | $2.953 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026